Your browser doesn't support javascript.
loading
Corrigendum to 'Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial: [Annals of Oncology Volume 32, Issue 10, October 2021, Pages 1276-1285].
Hughes, B G M; Munoz-Couselo, E; Mortier, L; Bratland, Å; Gutzmer, R; Roshdy, O; González Mendoza, R; Schachter, J; Arance, A; Grange, F; Meyer, N; Joshi, A; Billan, S; Zhang, P; Gumuscu, B; Swaby, R F; Grob, J-J.
Afiliação
  • Hughes BGM; Cancer Care Services, Royal Brisbane and Women's Hospital, Herston; University of Queensland, Brisbane, Australia. Electronic address: brett.hughes@health.qld.gov.au.
  • Munoz-Couselo E; Hospital Vall D Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Mortier L; University of Lille, Inserm U 1189, CHU Lille, Lille, France.
  • Bratland Å; Oslo Universitetssykehus, Oslo, Norway.
  • Gutzmer R; Department of Dermatology and Allergy, Skin Cancer Center Hannover, Medizinische Hochschule Hannover, Hanover; Mühlenkreiskliniken, Ruhr University Bochum Campus Minden, Minden, Germany.
  • Roshdy O; Jewish General Hospital, Montreal, Canada.
  • González Mendoza R; Centro Estatal de Cancerologiade Chihuahua, Chihuahua, Mexico.
  • Schachter J; Chaim Sheba Medical Center at Tel HaShomer, Ramat Gan, Israel.
  • Arance A; Hospital Clínic i Provincial de Barcelona, Barcelona, Spain.
  • Grange F; Dermatology Department, Center Hospitalier Universitaire de Reims-Hôpital Robert Debre, Reims.
  • Meyer N; Dermatology, Institut Universitaire du Cancer and CHU de Toulouse, Toulouse, France.
  • Joshi A; Department of Medical Oncology, Townsville University Hospital, Townsville, Australia.
  • Billan S; The Head and Neck Center, Oncology Department, Rambam Health Care Campus, Haifa, Israel.
  • Zhang P; Merck & Co., Inc., Kenilworth, USA.
  • Gumuscu B; Merck & Co., Inc., Kenilworth, USA.
  • Swaby RF; Merck & Co., Inc., Kenilworth, USA.
  • Grob JJ; Service de Dermatologie et Cancérologie Cutanée, Aix-Marseille University, Marseille, France.
Ann Oncol ; 33(8): 853, 2022 Aug.
Article em En | MEDLINE | ID: mdl-35690517

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article